List of articles with "Innovent Biologics"

Innovent-Takeda Partnership

2025-12-04 23:43:26

China Suzhou Innovent Biologics cancer therapies Takeda

Mazdutide Review Accepted

2025-11-25 09:05:11

China Suzhou Innovent Biologics Mazdutide China NMPA

Innovent Biologics Milestone

2025-11-24 00:02:49

China Suzhou biopharmaceuticals Innovent Biologics Hang Seng Index

Innovent Research Highlights

2025-11-05 00:10:23

China Suzhou Innovent Biologics IBI3011 IBI3034

Innovent and Takeda Alliance

2025-10-22 00:35:32

China Suzhou Innovent Biologics Immuno-Oncology Takeda

Mazdutide Approval

2025-09-19 10:06:11

China Suzhou Innovent Biologics Type 2 Diabetes Mazdutide

Ollin Unveils IBI324 Updates

2025-09-18 04:25:25

USA San Francisco Innovent Biologics Ollin Biosciences IBI324

Innovent's EADV 2025 Showcase

2025-09-16 01:16:10

Suzhou Innovent Biologics EADV Congress IL-23p19

Innovent 2025 Growth Update

2025-08-27 10:18:27

China Suzhou biopharmaceuticals Innovent Biologics oncology

Innovent's IBI363 Approval

2025-08-25 00:11:20

United States FDA Approval San Francisco Innovent Biologics IBI363

Innovent's New Drug Approval

2025-08-05 00:04:12

United States FDA Approval San Francisco Innovent Biologics IBI3032

IBI343 Phase 1 Results

2025-07-17 00:04:43

China Suzhou Innovent Biologics gastric cancer IBI343

Mazdutide Trial in China

2025-06-16 00:12:18

China Suzhou Innovent Biologics OSA Mazdutide

Innovent's ADA Presentation

2025-06-13 01:04:41

USA Chicago Innovent Biologics Mazdutide ADA 85th

IBI363 Breakthrough

2025-06-05 00:26:21

China Suzhou Cancer Treatment Innovent Biologics IBI363

Innovent Biologics Data

2025-06-04 00:03:56

China Suzhou Innovent Biologics Lung Cancer IBI363

IBI343 Phase 1 Results

2025-06-03 01:09:09

China Suzhou Innovent Biologics IBI343 ASCO 2025

Innovent Biologics IBI363 Update

2025-06-02 00:02:33

China Suzhou Innovent Biologics ASCO 2025 IBI363

IBI363 Data at ASCO 2025

2025-06-01 01:51:20

China Suzhou Innovent Biologics IBI363 melanoma

Innovent's Psoriasis Study

2025-05-29 01:38:24

China Suzhou Innovent Biologics Picankibart Psoriasis Treatment

Innovent ESG Report 2024

2025-05-19 00:12:25

Sustainability China Suzhou Innovent Biologics ESG Report

Mazdutide Phase 3 Trial Begins

2025-05-16 00:08:52

China Suzhou Innovent Biologics Semaglutide Mazdutide

Innovent's Phase 2 Study

2025-05-07 00:14:44

China Suzhou Innovent Biologics Diabetic Macular Edema Efdamrofusp Alfa

Efdamrofusp Alfa Update

2025-05-06 00:01:51

United States Innovent Biologics Salt Lake City Efdamrofusp Alfa Phase 2 Clinical Trial

Innovent's IBI3020 Phase 1 Study

2025-04-30 00:12:25

China Suzhou Innovent Biologics IBI3020 CEACAM5

Innovent's IBI363 Designation

2025-04-01 01:04:53

China Suzhou Innovent Biologics IBI363 melanoma

Innovent's AACR 2025 Preview

2025-03-27 01:20:42

USA Chicago Innovent Biologics oncology Biopharmaceutical

Innovent's 2024 Results

2025-03-26 10:30:02

China Suzhou biopharmaceuticals Innovent Biologics RMB20bn Target

Innovent's Breakthrough in Cancer Therapy

2025-02-24 00:03:19

China Suzhou Innovent Biologics Ipilimumab Sintilimab

Innovent's Fast Track Success

2025-02-17 00:10:15

Innovent Biologics FDA Fast Track IBI363

Innovent's Future Innovations

2025-01-16 23:09:23

USA biopharmaceuticals San Francisco Innovent Biologics oncology

IBI343 Breakthrough Status

2025-01-16 00:02:18

China Suzhou Innovent Biologics pancreatic cancer IBI343

Innovent and Lilly Team Up

2024-12-15 23:58:19

China Suzhou Innovent Biologics Eli Lilly Jaypirca

Innovent's IBI343 Advances

2024-12-09 00:03:16

Innovent Biologics pancreatic cancer IBI343

Innovent's NRDL Expansion

2024-11-28 04:15:20

China Olverembatinib Suzhou Innovent Biologics SINTBILO®

Innovent's Oncology Breakthroughs

2024-11-25 00:32:21

China Suzhou Innovent Biologics oncology ESMO Asia